肿瘤ENPP1(CD203a)/触珠蛋白轴利用髓源性抑制细胞促进乳腺癌放疗后局部复发
该研究在新建模型中识别出ENPP1与乳腺癌术后放疗后局部复发密切相关,ENPP1高表达循环肿瘤细胞通过自我播种机制导致复发,该过程需要多形核髓源性抑制细胞浸润和中性粒细胞胞外诱捕网形成。遗传学和药理学抑制ENPP1或阻断NET可延长无复发生存,与分次照射联合时消除局部复发。机制上ENPP1生成的腺苷能代谢物增强触珠蛋白表达,后者促进髓系侵袭和NET形成,复发肿瘤中ENPP1和NET形成显著增加,高ENPP1或HP水平与不良预后相关。
要点
- ENPP1高表达循环肿瘤细胞通过自我播种机制促进乳腺癌术后放疗后局部复发。
- 该过程依赖多形核髓源性抑制细胞浸润和中性粒细胞胞外诱捕网形成。
- 抑制ENPP1或阻断NET可延长无复发生存,联合分次照射可消除局部复发。
核心结论
- 肿瘤细胞利用ENPP1/HP轴将炎症与免疫重塑联系起来,促进局部复发。
- 阻断该轴可损害肿瘤定植、阻碍免疫抑制并消除NET形成,为治疗局部复发提供新机会。
研究设计与样本
- 研究采用 refined new model 识别与局部复发相关的ENPP1。
- 研究涉及乳腺癌术后放疗后局部复发患者肿瘤样本分析。
主要发现
- ENPP1高表达循环肿瘤细胞通过自我播种机制导致复发,需要多形核髓源性抑制细胞浸润和NET形成。
- 遗传学和药理学抑制ENPP1或阻断NET可延长无复发生存。
- 与分次照射联合时,ENPP1消除可 obliterate 局部复发。
- 机制上ENPP1生成的腺苷能代谢物增强触珠蛋白表达,后者促进髓系侵袭和NET形成。
- 复发的人乳腺癌肿瘤中ENPP1和NET形成显著增加,高ENPP1或HP水平与不良预后相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ABSTRACT: Locoregional failure (LRF) in patients with breast cancer post-surgery and post-irradiation is linked to a dismal prognosis. In a refined new model, we identified ectonucleotide pyrophosphatase/phosphodiesterase 1/CD203a (ENPP1) to be closely associated with LRF. ENPP1hi circulating tumor cells (CTC) contribute to relapse by a self-seeding mechanism. This process requires the infiltration of polymorphonuclear myeloid-derived suppressor cells and neutrophil extracellular trap (NET) formation. Genetic and pharmacologic ENPP1 inhibition or NET blockade extends relapse-free survival. Furthermore, in combination with fractionated irradiation, ENPP1 abrogation obliterates LRF. Mechanistically, ENPP1-generated adenosinergic metabolites enhance haptoglobin (HP) expression. This inflammatory mediator elicits myeloid invasiveness and promotes NET formation. Accordingly, a significant increase in ENPP1 and NET formation is detected in relapsed human breast cancer tumors. Moreover, high ENPP1 or HP levels are associated with poor prognosis. These findings unveil the ENPP1/HP axis as an unanticipated mechanism exploited by tumor cells linking inflammation to immune remodeling favoring local relapse. SIGNIFICANCE: CTC exploit the ENPP1/HP axis to promote local recurrence post-surgery and post-irradiation by subduing myeloid suppressor cells in breast tumors. Blocking this axis impairs tumor engraftment, impedes immunosuppression, and obliterates NET formation, unveiling new opportunities for therapeutic intervention to eradicate local relapse and ameliorate patient survival. This article is highlighted in the In This Issue feature, p. 1171.
引用
- Ruiz-Fernández de Córdoba B, Moreno H, Valencia K, et al. Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer. Cancer Discov. 2022. PMID: 35191482. doi:10.1158/2159-8290.CD-21-0932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。